Negocios · 25/11/19971 min de lectura
Intermountain Health Care, Inc.; Revocation of U.S. License No. 0729
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 0729) and the product licenses issued to Intermountain Health Care, Inc., for the manufacture of Whole Blood, Red Blood Cells, Cryoprecipitated AHF, Plasma, and Platelets. The firm voluntarily surrendered its licenses as part of a Consent Decree of Permanent Injunction.